1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with 1-methyl-4-phenylpyridinium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruyama, W; Matsubara, K; Naoi, M; Ota, M; Takahashi, T | 1 |
| Ohta, S; Yamakawa, T | 1 |
| Absi, E; Ayala, A; Cano, J; Castaño, A; Machado, A; Parrado, J | 1 |
3 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Structural studies of condensation products of biogenic amines as inhibitors of tryptophan hydroxylase.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Biogenic Amines; Brain; Dopamine; Isoquinolines; Kinetics; Male; Rats; Rats, Wistar; Structure-Activity Relationship; Tetrahydroisoquinolines; Tryptophan; Tryptophan Hydroxylase | 1994 |
Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antipsychotic Agents; Biogenic Amines; Carbolines; Haloperidol; Harmine; Isoquinolines; Male; Mitochondria; Neurotoxins; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines | 1999 |
The endogenous amine 1-methyl-1,2,3,4- tetrahydroisoquinoline prevents the inhibition of complex I of the respiratory chain produced by MPP(+).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Brain; Corpus Striatum; Electron Transport Complex I; Isoquinolines; Male; Mitochondria; Mitochondria, Liver; NADH, NADPH Oxidoreductases; Oxygen Consumption; Rats; Rats, Wistar; Synaptosomes; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2000 |